AquaBounty Technologies
AQBAquaBounty Technologies is a biotechnology and aquaculture company that historically specialized in the development and land-based farming of genetically engineered Atlantic salmon.
Earnings
Next report
Date not yet announcedCompetitors
By market cap
By revenue growth
Profile
AquaBounty Technologies is a biotechnology and aquaculture company that historically specialized in the development and land-based farming of genetically engineered Atlantic salmon. Following a significant strategic restructuring and the sale of its core intellectual property and operational farms, the company is currently focused on maximizing the value of its remaining physical assets. Its primary objective involves the potential sale or strategic resolution of its large-scale recirculating aquaculture system construction project in Ohio.
The company is currently in a transitional phase, moving away from its position as a pioneer in genetically engineered seafood toward a focus on asset divestiture and strategic alternatives.
FAQ
- What is AquaBounty Technologies's market cap?
- AquaBounty Technologies (AQB) has a market capitalization of $4.7M and trades on NASDAQ.
- Who are AquaBounty Technologies's competitors?
- AquaBounty Technologies's key competitors include CADIZ, Inc., Hydrofarm Holdings Group, Inc. Common Stock, Nocera, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- What subsidiaries does AquaBounty Technologies have?
- AquaBounty Technologies's subsidiaries include AquaBounty Canada.
- Where is AquaBounty Technologies headquartered?
- AquaBounty Technologies is headquartered in United States of America and employs approximately 115 people. It has been publicly traded since 2017.